NanoSanguis
2015
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
4
INVESTORS
Description
Developer of red blood cell substitute intended to offer an alternative to natural blood. The company's red blood cell substitute uses a biotechnology method for producing synthetic oxygen carrier which is stable for at least one year of storage and is developing blood substitute based on full physiological, buffered fluid composed of balanced minerals compatible with human organism, enabling clinics to meet the rapidly increasing blood deficit.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
- Ludwika Waryńskiego 1
- Warsaw, 00-645
- Poland
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore NanoSanguis’s full profile, request a free trial.
NanoSanguis Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Grant | Completed | Startup |
NanoSanguis Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| European Regional Development Fund | Other | 000 0000 | 000000 0 | |||
| Giza Polish Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| StarFinder | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Startup Hub Poland | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
NanoSanguis Executive Team (3)
NanoSanguis Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Maciek Sadowski | Startup Hub Poland | Member of the Supervisory Board | 000 0000 | |
| Marek Borzestowski | Giza Polish Ventures | President of the Supervisory Board | 000 0000 | |
| Paweł Ciach | Self | Member of the Supervisory Board | 000 0000 | |
| Tomasz Ciach | Self | Co-Founder, Research Co-ordinator & Board Member | 000 0000 |